SG Americas Securities LLC Decreases Holdings in ARK Genomic Revolution ETF $ARKG

SG Americas Securities LLC lowered its position in ARK Genomic Revolution ETF (BATS:ARKG) by 84.6% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,786 shares of the company’s stock after selling 86,735 shares during the period. SG Americas Securities LLC’s holdings in ARK Genomic Revolution ETF were worth $417,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of ARKG. Rockefeller Capital Management L.P. boosted its position in ARK Genomic Revolution ETF by 1.9% during the fourth quarter. Rockefeller Capital Management L.P. now owns 24,243 shares of the company’s stock worth $702,000 after purchasing an additional 461 shares in the last quarter. FWL Investment Management LLC increased its position in shares of ARK Genomic Revolution ETF by 17.1% in the third quarter. FWL Investment Management LLC now owns 3,239 shares of the company’s stock valued at $90,000 after buying an additional 474 shares in the last quarter. StoneX Group Inc. increased its position in shares of ARK Genomic Revolution ETF by 6.5% in the fourth quarter. StoneX Group Inc. now owns 8,746 shares of the company’s stock valued at $253,000 after buying an additional 530 shares in the last quarter. Allworth Financial LP raised its stake in shares of ARK Genomic Revolution ETF by 39.9% during the 4th quarter. Allworth Financial LP now owns 2,061 shares of the company’s stock worth $60,000 after buying an additional 588 shares during the last quarter. Finally, Daymark Wealth Partners LLC raised its stake in shares of ARK Genomic Revolution ETF by 8.7% during the 4th quarter. Daymark Wealth Partners LLC now owns 8,701 shares of the company’s stock worth $252,000 after buying an additional 700 shares during the last quarter.

ARK Genomic Revolution ETF Trading Down 1.7%

ARK Genomic Revolution ETF stock opened at $41.87 on Thursday. ARK Genomic Revolution ETF has a 52 week low of $22.73 and a 52 week high of $44.47. The firm’s 50-day simple moving average is $34.35 and its 200 day simple moving average is $31.04.

ARK Genomic Revolution ETF Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.